FOXR2 and primitive neuroectodermal tumor: CNS neuroblastoma, FOXR2‐activated was described by Sturm D. et al. [17] when it was observed that a subset of the tumors diagnosed in the past as CNS primitive neuroectodermal tumors have FOXR2 rearrangements and overlapping methylation profiles.